Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)

Clinical trial NCT00211601 · COMPLETED

Trial details

NCT number: NCT00211601
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chemotherapy Induced Nausea and Vomiting

Start date: 2004-08-01
Primary completion: 2005-12-01
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.